Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX) witnessed volume of 1.43 million shares during last trade however it holds an average trading capacity of 593,634.00 shares. IDIX last trade opened at $6.49 reached intraday low of $6.47 and went +9.78% up to close at $6.96.
IDIX has a market capitalization $668.13 million and an enterprise value at $577.20 million. Trailing twelve months price to sales ratio of the stock was 57.90. In profitability ratios, operating profit margin in past twelve months appeared at -429.96%.
The company made a return on asset of -53.49% in past twelve months. In the period of trailing 12 months it generated revenue amounted to $11.54 million gaining $0.16 revenue per share. Its year over year, quarterly growth of revenue was 49.10%.
According to preceding quarter balance sheet results, the company had $31.41 million cash in hand making cash per share at 0.33. The total debt was $0.00 billion. Moreover its current ratio according to same quarter results was 2.28 and book value per share was -0.56.
Looking at the trading information, the stock price history displayed that its S&P500 52 Week Change illustrated 19.95% where the stock current price exhibited up beat from its 50 day moving average price of $5.40 and remained above from its 200 Day Moving Average price of $4.39.
IDIX holds 96.00 million outstanding shares with 60.19 million floating shares where insider possessed 46.21% and institutions kept 41.80%.
No comments:
Post a Comment